The analyst, Michael Weinstein, said the device industry has now abandoned "its hard-line stance against increased taxation" but cautioned that the actual amount is "far from final."
Under a deal with White House and Senate negotiators, Mr. Weinstein said the industry is likely to end up paying 1.5-2 percent of $120 billion in U.S. sales revenue.
Read Bloomberg News’ report on the medical device tax.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
